PROTAC Selection

产品编号	产品名称
T16667	PROTAC Sirt2 Degrader-1	PROTAC Sirt2 Degrader-1 is a SirReal-based PROTAC, acts as a Sirt2 degrader, composed of a highly potent and isotype-selective Sirt2 inhibitor, a linker, and a bona fide cereblon ligand for E3 ubiquitin ligase. PROTAC Sirt2 Degrader-1 shows an IC50 of 0.25 μM for Sirt2, with no effect on Sirt1/Sirt3 (IC50s > 100 μM)[1].
T17249	VZ185
T11292	FKBP12 PROTAC dTAG-7
T5438	PROTAC CDK9 Degrader-1	PROTAC CDK9 Degrader-1 是一种选择性 CDK9 降解剂，是由Cereblon 配体和CDK 配体相连的PROTAC。
T13839	PROTAC ER Degrader-4	PROTAC ER Degrader-4 is a PROTAC degrader of the estrogen receptor (ER) with an IC50 of 0.8 nM.
T11664	INY-03-041	INY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide.
T12556	PROTAC B-Raf degrader 1	PROTAC B-Raf degrader 1 is a proteolysis targeting chimera (PROTAC) for the degradation of B-Raf,PROTAC B-Raf degrader 1 With anti-cancer activity.
T84316	ARV-393	ARV-393 是一种 BCL6 PROTAC 降解剂，在 DLBCL 和 BL 细胞系中的 DC50 和 GI50 值均 <1 nM。ARV-393 在多个肿瘤异种移植模型中，可起到抑制肿瘤体积的作用。
T13846	PROTAC RIPK degrader-2	PROTAC RIPK degrader-2 is a nonpeptidic PROTAC ,and potently targets serine-threonine kinase RIPK2 and has highly selective for RIPK2 degradation.
T13849	PROTAC BET Degrader-1	PROTAC BET Degrader-1 is a potent degrader of BET based on PROTAC.
T18631	PROTAC MDM2 Degrader-1	PROTAC MDM2 Degrader-1 is a chemical compound that utilizes PROTAC technology to degrade MDM2. This compound is comprised of a highly effective MDM2 inhibitor, a linker, and the MDM2 ligand for E3 ubiquitin ligase[1].
T18633	PROTAC MDM2 Degrader-3	PROTAC MDM2 Degrader-3 is a compound that leverages PROTAC technology to degrade MDM2. It consists of a highly effective MDM2 inhibitor, a linker, and the MDM2 ligand for E3 ubiquitin ligase[1].
T18607	PROTAC ER Degrader-3	PROTAC ER Degrader-3, an intermediate for the synthesis of PAC, specifically compound LP2. PAC serves as the linker for ADCs and PROTACs that are conjugated to an antibody. Notably, when PAC is conjugated to an antibody, it exhibits enhanced degradation of estrogen receptor-alpha (ERα) compared to PROTAC alone [1].
T17910	(S,R,S)-AHPC-PEG2-C4-Cl
T17911	(S,R,S)-AHPC-C6-PEG3-C4-Cl
T13842	PROTAC IRAK4 degrader-1	PROTAC IRAK4 degrader-1 is a PROTAC (proteolysis-targeting chimera) compound that targets and degrades interleukin-1 receptor-associated kinase 4 (IRAK4).
T13835	PROTAC BRD4 Degrader-3	PROTAC BRD4 Degrader-3 is an efficacious degrader of PROTAC BRD4.
T13785	MZP-54
T14549	BETd-246	BETd-246 is an inhibitor of second-generation and PROTAC-based BET bromodomain (BRD), show antitumor activity.
T12560	PROTAC BRD9 Degrader-1	PROTAC BRD9 Degrader-1 is a leading PROTAC BRD9 chemical degrader with an IC50 of 13.5 nM.

注册成功

PROTAC Selection